Shows anticancer activity of maleimide derivatives in K562 and KG-1 cancer cells, suggesting potential therapeutic applications.
A series of 4-(2,5-dioxo-2,5-dihydro-1 H -pyrrol-1-yl)- N ′-[(substituted phenyl)methylidene]benzohydrazides ( BF 1–12 ) were synthesized and screened for in vitro anticancer activity against K562 and KG-1 cancer cell lines.
No takes yet. Share an insight, caveat, or question.
Bhat et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: